Retinal and Choroidal Changes of Vitreoretinal Lymphoma from Active to Remission Phase after Intravitreal Rituximab

REFERENCES

• Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium. Oncologist. 2011;16:1589–1599. doi:10.1634/theoncologist.2011-0210.
   PubMed Web of Science ®Google Scholar
• Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmol. 1993;100:1399–1406.
   PubMed Web of Science ®Google Scholar
• Raja H, Salomao DR, Viswanatha DS and Pulido JS. Prevalence of Myd88 L265p mutation in histologically proven, diffuse large B-cell vitreoretinal lymphoma. Retina. 2016;36:624–628. doi:10.1097/IAE.0000000000000996.
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Ferreri AJM, Giuffre C, et al. Myd88 L265p mutation detection in the aqueous humor of patients with vitreoretinal lymphoma. Retina. 2019;39:679–684.
   Web of Science ®Google Scholar
• Barry RJ, Tasiopoulou A, Murray PI, et al. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis. Br J Ophthalmol. 2018. doi:10.1136/bjophthalmol-2017-311612.
   PubMedGoogle Scholar
• Keino H, Okada AA, Watanabe T, et al. Spectral-domain optical coherence tomography patterns in intraocular lymphoma. Ocul Immunol Inflamm. 2016;24:268–273. doi:10.3109/09273948.2014.1002568.
   PubMed Web of Science ®Google Scholar
• Ishida T, Ohno-Matsui K, Kaneko Y, et al. Fundus autofluorescence patterns in eyes with primary intraocular lymphoma. Retina. 2010;30:23–32. doi:10.1097/IAE.0b013e3181b408a2.
   PubMed Web of Science ®Google Scholar
• Lavine JA, Singh AD, Sharma S, Baynes K, Lowder CY, Srivastava SK. Ultra-widefield multimodal imaging of primary vitreoretinal lymphoma. Retina. 2018. doi:10.1097/IAE.0000000000002260.
   PubMed Web of Science ®Google Scholar
• Morara M, Foschi F, Veronese C, et al. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge: the supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma. Int Ophthalmol. 2018;38:353–361. doi:10.1007/s10792-016-0422-1.
   PubMed Web of Science ®Google Scholar
• Mapelli C, Invernizzi A, Barteselli G, et al. Multimodal imaging of vitreoretinal lymphoma. Ophthalmologica. 2016;236:166–174. doi:10.1159/000447412.
   PubMed Web of Science ®Google Scholar
• Dolz-Marco R, Gallego-Pinazo R, Jung JJ, Freund KB, Diaz-Llopis M. Sequential multimodal imaging findings in a case of primary vitreoretinal lymphoma. Retin Cases Brief Rep. 2014;8:314–317. doi:10.1097/ICB.0000000000000053.
   PubMedGoogle Scholar
• Liang F, Barale PO, Hoang Xuan K, Paques M and Sahel JA. Subretinal lymphomatous infiltration in primary intraocular lymphoma revealed by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2011;249:1425–1427. doi:10.1007/s00417-011-1669-x.
   PubMed Web of Science ®Google Scholar
• Liu TY, Ibrahim M, Bittencourt M, Sepah YJ, Do DV and Nguyen QD. Retinal optical coherence tomography manifestations of intraocular lymphoma. J Ophthalmic Inflamm Infect. 2012;2:215–218. doi:10.1007/s12348-012-0072-z.
   PubMedGoogle Scholar
• Forooghian F, Merkur AB, White VA, Shen D, Chan CC. High-definition optical coherence tomography features of primary vitreoretinal lymphoma. Ophthalmic Surg Lasers Imaging. 2011;42:e97–99. Online. doi:10.3928/15428877-20110922-02.
   PubMedGoogle Scholar
• Kaushik M, Pulido JS, Schild SE and Stafford S. Risk of radiation retinopathy in patients with orbital and ocular lymphoma. Int J Radiat Oncol Biol Phys. 2012;84:1145–1150. doi:10.1016/j.ijrobp.2011.12.097.
   PubMed Web of Science ®Google Scholar
• Teckie S, Yahalom J. Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone. Leuk Lymphoma. 2014;55:795–801. doi:10.3109/10428194.2013.819576.
   PubMed Web of Science ®Google Scholar
• Saito T, Ohguro N, Iwahashi C and Hashida N. Optical coherence tomography manifestations of primary vitreoretinal lymphoma. Graefes Arch Clin Exp Ophthalmol. 2016;254:2319–2326. doi:10.1007/s00417-016-3395-x.
   PubMed Web of Science ®Google Scholar
• Saleh M, Nikolitch K, Bourcier T, Speeg C and Gaucher D. Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate. Graefes Arch Clin Exp Ophthalmol. 2012;250:761–764. doi:10.1007/s00417-011-1718-5.
   PubMed Web of Science ®Google Scholar
• Abrey LE, Batchelor TT, Ferreri AJ, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol. 2005;23:5034–5043. doi:10.1200/JCO.2005.13.524.
   PubMed Web of Science ®Google Scholar
• Spaide RF, Koizumi H and Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496–500. doi:10.1016/j.ajo.2008.05.032.
   PubMed Web of Science ®Google Scholar
• Staurenghi G, Sadda S, Chakravarthy U, Spaide RF. International nomenclature for optical coherence tomography P. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN*OCT consensus. Ophthalmol. 2014;121:1572–1578.
   PubMed Web of Science ®Google Scholar
• Kl L, Us S, Gm C, et al. Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. Br J Ophthalmol. 2014;98:99–103. doi:10.1136/bjophthalmol-2013-304043.
   PubMed Web of Science ®Google Scholar
• Yeh S, Wilson DJ. Combination intravitreal rituximab and methotrexate for massive subretinal lymphoma. Eye (Lond). 2010;24:1625–1627. doi:10.1038/eye.2010.111.
   PubMed Web of Science ®Google Scholar
• Raja H, Snyder MR, Johnston PB, et al. Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma. PLoS One. 2013;8:e65627. doi:10.1371/journal.pone.0065627.
   PubMed Web of Science ®Google Scholar
• Hashida N, Ohguro N, Nishida K. Efficacy and complications of intravitreal rituximab injection for treating primary vitreoretinal lymphoma. Transl Vis Sci Technol. 2012;1:1. doi:10.1167/tvst.1.3.1.
   PubMed Web of Science ®Google Scholar
• Egawa M, Mitamura Y, Hayashi Y and Naito T. Spectral-domain optical coherence tomographic and fundus autofluorescence findings in eyes with primary intraocular lymphoma. Clin Ophthalmol. 2014;8:335–341. doi:10.2147/OPTH.S58114.
   PubMedGoogle Scholar
• Casady M, Faia L, Nazemzadeh M, Nussenblatt R, Chan CC and Sen HN. Fundus autofluorescence patterns in primary intraocular lymphoma. Retina. 2014;34:366–372. doi:10.1097/IAE.0b013e31829977fa.
   PubMed Web of Science ®Google Scholar
• Dickson D, Agarwal A, Sadiq MA, et al. Assessment of vitreous haze using ultra-wide field retinal imaging. J Ophthalmic Inflamm Infect. 2016;6:35. doi:10.1186/s12348-016-0105-0.
   PubMed Web of Science ®Google Scholar
• Fardeau C, Lee CP, Merle-Beral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147(886–894):894 e881. doi:10.1016/j.ajo.2008.12.025.
   Google Scholar
• Deak GG, Goldstein DA, Zhou M, Fawzi AA, Jampol LM. Vertical hyperreflective lesions on optical coherence tomography in vitreoretinal lymphoma. JAMA Ophthalmol. 2018. doi:10.1001/jamaophthalmol.2018.5835.
   Google Scholar
• Jang HS, Sepah YJ, Sophie R, et al. Longitudinal spectral domain optical coherence tomography changes in eyes with intraocular lymphoma. J Ophthalmic Inflamm Infect. 2013;3:59. doi:10.1186/1869-5760-3-59.
   PubMedGoogle Scholar
• Egawa M, Mitamura Y, Hayashi Y, Semba K and Naito T. Changes of fundus autofluorescence and spectral-domain optical coherence tomographic findings after treatment of primary intraocular lymphoma. J Ophthalmic Inflamm Infect. 2014;4:7. doi:10.1186/1869-5760-4-7.
   PubMedGoogle Scholar
• Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina. 2011;31:1609–1619. doi:10.1097/IAE.0b013e3182247535.
   PubMed Web of Science ®Google Scholar
• Introini U, Casalino G, Querques G, Gimeno AT, Scotti F and Bandello F. Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization. Eye (Lond). 2012;26:976–982. doi:10.1038/eye.2012.75.
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang AG, Lin YH, Huang YM, Lee FL and Lee SM. Optical coherence tomography in resolution of photoreceptor damage in multiple evanescent white dot syndrome. J Chin Med Assoc. 2012;75:663–666. doi:10.1016/j.jcma.2012.08.011.
   PubMed Web of Science ®Google Scholar
• Merkoudis N, Granstam E. Acute retinal pigment epitheliitis: optical coherence tomography findings at onset and follow-up. Acta Ophthalmol. 2013;91:e84–85. doi:10.1111/j.1755-3768.2012.02442.x.
   PubMed Web of Science ®Google Scholar
• Turgut B, Yildirim H. The causes of hyperreflective dots in optical coherence tomography excluding diabetic macular edema and retinal venous occlusion section sign. Open Ophthalmol J. 2015;9:36–40. doi:10.2174/1874364101509010036.
   PubMed Web of Science ®Google Scholar
• Hwang HS, Chae JB, Kim JY and Kim DY. Association between hyperreflective dots on spectral-domain optical coherence tomography in macular edema and response to treatment. Invest Ophthalmol Vis Sci. 2017;58:5958–5967. doi:10.1167/iovs.17-22725.
   PubMed Web of Science ®Google Scholar
• Parodi MB, Arrigo A, Romano F, et al. Hyperreflective foci number correlates with choroidal neovascularization activity in angioid streaks. Invest Ophthalmol Vis Sci. 2018;59:3314–3319. doi:10.1167/iovs.18-24291.
   PubMed Web of Science ®Google Scholar
• Bolz M, Schmidt-Erfurth U, Deak G, et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009;116:914–920. doi:10.1016/j.ophtha.2008.12.039.
   PubMed Web of Science ®Google Scholar
• Chan CC, Fischette M, Shen D, Mahesh SP, Nussenblatt RB and Hochman J. Murine model of primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2005;46:415–419. doi:10.1167/iovs.04-0869.
   PubMed Web of Science ®Google Scholar
• Mashayekhi A, Shukla SY, Shields JA and Shields CL. Choroidal lymphoma: clinical features and association with systemic lymphoma. Ophthalmology. 2014;121:342–351. doi:10.1016/j.ophtha.2013.06.046.
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Kim JH and Lee BR. Choroidal change in acute anterior uveitis associated with human leukocyte antigen-B27. PLoS One. 2017;12:e0180109. doi:10.1371/journal.pone.0180109.
   PubMed Web of Science ®Google Scholar
• Nakayama M, Keino H, Okada AA, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Retina. 2012;32:2061–2069. doi:10.1097/IAE.0b013e318256205a.
   PubMed Web of Science ®Google Scholar